A Community Practitioner’s Guide to Contemporary Management of Polycythemia Vera: Data Review and Case Challenges Illustrating Current Best Practice
Download these slides covering community team management of polycythemia vera, including risk stratification directing cytoreductive therapy, dose optimization considering response and tolerance, and identification of factors directing treatment switch.
Assistant Member Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa, Florida
John Mascarenhas, MD
Director, Adult Leukemia Program Leader, Myeloproliferative Disorders Clinical Research Program Division of Hematology/Oncology Tisch Cancer Institute Professor of Medicine Icahn School of Medicine at Mount Sinai New York, New York
Provided by Clinical Care Options, LLC
Supported by educational grants from Incyte Corporation and PharmaEssentia USA Corporation.
PharmaEssentia USA Corporation
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.